Professor Philip Sloan
Anna Long
Dr Max Robinson
| Developing and Validating a Multivariable Prognostic-Predictive Classifier for Treatment Escalation of Oropharyngeal Squamous Cell Carcinoma: The PREDICTR-OPC Study | 2024 |
|
Dr Max Robinson
Dr Paul Brennan
| Development and external validation of a head and neck cancer risk prediction model | 2024 |
|
Dr Max Robinson
| Standardised definitions and diagnostic criteria for extranodal extension detected on histopathological examination in head and neck cancer: Head and Neck Cancer International Group consensus recommendations | 2024 |
|
Dr Max Robinson
| A risk prediction model for head and neck cancers incorporating lifestyle factors, HPV serology and genetic markers | 2023 |
|
Dr Max Robinson
| A digital score of tumour-associated stroma infiltrating lymphocytes predicts survival in head and neck squamous cell carcinoma | 2022 |
|
Daniel Lin
Dr Max Robinson
Professor Vinidh Paleri
| Robotic lateral oropharyngectomy following diagnostic tonsillectomy is oncologically safe in patients with human papillomavirus-related squamous cell cancer: Long-term results | 2022 |
|
Dr Hans Sathasivam
Professor Philip Sloan
Professor Peter Thomson
Dr Max Robinson
| The clinical utility of contemporary oral epithelial dysplasia grading systems | 2022 |
|
Dr Max Robinson
| Germline determinants of humoral immune response to HPV-16 protect against oropharyngeal cancer | 2021 |
|
Dr Hans Sathasivam
Dr Ralf Kist
Professor Philip Sloan
Professor Peter Thomson
Michael Nugent
et al. | Predicting the clinical outcome of oral potentially malignant disorders using transcriptomic-based molecular pathology | 2021 |
|
Richard Walton
Dr Max Robinson
Professor Marco Carrozzo
| A service evaluation of the diagnostic testing for mucous membrane pemphigoid in a UK Oral Medicine Unit | 2020 |
|
Dr Hans Sathasivam
John Casement
Professor Philip Sloan
Dr Max Robinson
Dr Ralf Kist
et al. | Gene expression changes associated with malignant transformation of oral potentially malignant disorders | 2020 |
|
Dr Hans Sathasivam
Professor Philip Sloan
Dr Ralf Kist
Dr Max Robinson
| Prognostic Classifier for Oral Potentially Malignant Disorders: An Integrated Histopathological and Molecular approach | 2019 |
|
Dr Max Robinson
Nick West
| Quality assurance guidance for scoring and reporting for pathologists and laboratories undertaking clinical trial work | 2019 |
|
Dr Max Robinson
| Recommendations for determining HPV status in patients with oropharyngeal cancers under TNM8 guidelines: a two-tier approach | 2019 |
|
Dr Max Robinson
Professor Philip Sloan
| The use of digital pathology and image analysis in clinical trials | 2019 |
|
Dr Max Robinson
Professor Philip Sloan
Dr Andrew Hall
| Training and accreditation standards for pathologists undertaking clinical trial work | 2019 |
|
Dr Hans Sathasivam
Benjamin Cosway
Professor Vinidh Paleri
Matt Kennedy
Dr Rachel Pearson
et al. | Clinicopathological features of squamous cell carcinoma of the oral cavity and oropharynx in young patients | 2018 |
|
Dr Hans Sathasivam
Paula Bradley
Professor Vinidh Paleri
Professor Philip Sloan
Dr Max Robinson
et al. | Concurrent HPV-related oropharyngeal carcinoma in four couples | 2018 |
|
Dr Max Robinson
| Development and external validation of nomograms in oropharyngeal cancer patients with known HPV-DNA status: a European Multicentre Study (OroGrams) | 2018 |
|
Dr Timothy Bates
Professor Jeffrey Pearson
Dr Max Robinson
Jason Powell
| Laryngeal candidiasis: our experience from sixty biopsy specimens | 2018 |
|
Dr Max Robinson
| Predictors of oropharyngeal cancer survival in Europe | 2018 |
|
Dr Max Robinson
| Radiotherapy plus cisplatin or cetuximab in low-risk human papillomavirus-positive oropharyngeal cancer (De-ESCALaTE HPV): an open-label randomised controlled phase 3 trial | 2018 |
|
Dr Hans Sathasivam
James O'Hara
Dr David Meikle
Dr Charles Kelly
Dr Max Robinson
et al. | Robotic lateral oropharyngectomy following diagnostic tonsillectomy is oncologically safe in patients with high risk human papillomavirus related squamous cell cancer | 2018 |
|
Professor Vinidh Paleri
Dr David Meikle
James O'Hara
Dr Max Robinson
| Transoral robotic surgery for residual and recurrent oropharyngeal cancers: Exploratory study of surgical innovation using the IDEAL framework for early-phase surgical studies | 2018 |
|
Dr Max Robinson
| HPV testing of head and neck cancer in clinical practice | 2017 |
|
Dr Max Robinson
| PET-NECK: A multicentre randomised Phase III non-inferiority trial comparing a positron emission tomography-computerised tomography-guided watch-and-wait policy with planned neck dissection in the management of locally advanced (N2/N3) nodal metastases in patients with squamous cell head and neck cancer | 2017 |
|
Dr Timothy Bates
Dr Michaela Goodson
Professor Peter Thomson
Professor Philip Sloan
Dr Ralf Kist
et al. | Changes in Epidermal Growth Factor Receptor Gene Copy Number during Oral Carcinogenesis | 2016 |
|
Professor Peter Thomson
Dr Max Robinson
| Combined effects of smoking and HPV16 in oropharyngeal cancer | 2016 |
|
Dr Max Robinson
| Genome-wide association analyses identify new susceptibility loci for oral cavity and pharyngeal cancer | 2016 |
|
Dr Max Robinson
Professor Vinidh Paleri
| Geographic variation in human papillomavirus-related oropharyngeal cancer: Data from 4 multinational randomized trials. | 2016 |
|
Dr Max Robinson
| HOPX functions as a tumour suppressor in head and neck cancer | 2016 |
|
Dr Max Robinson
Professor Philip Sloan
| HPV-Related Oropharynx Cancer in the United Kingdom: An Evolution in the Understanding of Disease Etiology | 2016 |
|
Dr Max Robinson
| Intraoperative sentinel lymph node evaluation: implications of cytokeratin 19 expression for the adoption of OSNA in oral squamous cell carcinoma | 2016 |
|
Dr Max Robinson
| Nasopharyngeal carcinoma: United Kingdom National Multidisciplinary Guidelines | 2016 |
|
Dr Max Robinson
Professor Philip Sloan
| Oropharyngeal cancer: United Kingdom National Multidisciplinary Guidelines | 2016 |
|
Dr Max Robinson
| Pathology-based staging for HPV-positive squamous carcinoma of the oropharynx | 2016 |
|
Dr Max Robinson
| PET-CT Surveillance versus Neck Dissection in Advanced Head and Neck Cancer | 2016 |
|
Dr Max Robinson
| PREDICTR Study: Biomarkers in Oro-Pharyngeal Squamous Cell Carcinoma | 2016 |
|
Michael Nugent
Dr Max Robinson
| Should we test for high-risk human papilloma virus in patients with oral dysplasia? | 2016 |
|
Dr Max Robinson
| Transoral laser microsurgery for oropharyngeal squamous cell carcinoma: A paradigm shift in therapeutic approach | 2016 |
|
Dr Max Robinson
| Human papillomavirus testing in diagnostic head and neck pathology | 2015 |
|
Dr Max Robinson
| IGF-1R expression is associated with HPV-negative status and adverse survival in head and neck squamous cell cancer | 2015 |
|
Robert Banks
Dr Max Robinson
| Juvenile xanthogranuloma: unusual intraoral finding | 2015 |
|
Professor Vinidh Paleri
Dr Max Robinson
| Multicentric human papillomavirus-associated head and neck squamous cell carcinoma | 2015 |
|
Dr Michaela Goodson
Professor Philip Sloan
Dr Max Robinson
Professor Peter Thomson
| Oral precursor lesions and malignant transformation - who, where, what, and when? | 2015 |
|
Dr Joanne Patterson
Dr Max Robinson
| PATHOS: a phase II/III trial of risk-stratified, reduced intensity adjuvant treatment in patients undergoing transoral surgery for Human papillomavirus (HPV) positive oropharyngeal cancer | 2015 |
|
Dr Max Robinson
| PET-NECK: A multi-centre, randomized, phase III, controlled trial (RCT) comparing PETCT guided active surveillance with planned neck dissection (ND) for locally advanced (N2/N3) nodal metastases (LANM) in patients with head and neck squamous cell cancer (HNSCC) treated with primary radical chemoradiotherapy (CRT) | 2015 |
|
Dr Anne Chambers
Dr Max Robinson
Robert Banks
Professor Philip Sloan
| Twenty-first-century oral hairy leukoplakia-a non-HIV-associated entity | 2015 |
|
Dr Max Robinson
| Human Papillomavirus Testing in Head and Neck Squamous Cell Carcinoma: Best Practice for Diagnosis | 2014 |
|
Professor Vinidh Paleri
Dr Max Robinson
| Patients with HPV-related tonsil squamous cell carcinoma rarely harbour oncogenic HPV infection at other pharyngeal sites | 2014 |
|
Dr Timothy Bates
Professor Peter Thomson
Professor Philip Sloan
Dr Max Robinson
Dr Ralf Kist
et al. | PAX9 expression in potentially malignant disorders and early stage squamous carcinoma of the oral cavity | 2014 |
|
Dr Timothy Bates
Dr Max Robinson
| Small Cell Neuroendocrine Carcinoma of the Oropharynx Harbouring Oncogenic HPV-Infection | 2014 |
|
Professor Philip Sloan
Dr Max Robinson
| Squamous Cell Carcinoma of the Head and Neck Outside the Oropharynx Is Rarely Human Papillomavirus Related | 2014 |
|
Dr Ralf Kist
Michelle Watson
Moira Crosier
Dr Max Robinson
Dr Julie Reichelt
et al. | The Formation of Endoderm-Derived Taste Sensory Organs Requires a Pax9-Dependent Expansion of Embryonic Taste Bud Progenitor Cells | 2014 |
|
Dr Ameena Diajil
Dr Max Robinson
Professor Philip Sloan
Professor Peter Thomson
| Clinical Outcome Following Oral Potentially Malignant Disorder Treatment: A 100 Patient Cohort Study | 2013 |
|
Dr Max Robinson
| Human Papillomavirus-associated oropharyngeal cancer: an observational study of diagnosis, prevalence and prognosis in a UK population | 2013 |
|
Dr Max Robinson
Professor Vinidh Paleri
| Oncogenic human papillomavirus-associated nasopharyngeal carcinoma: an observational study of correlation with ethnicity, histological subtype and outcome in a UK population | 2013 |
|
Dr Max Robinson
Professor Vinidh Paleri
| Salivary gland swellings | 2013 |
|
Dr Michael Drinnan
Dr Max Robinson
Dr David Meikle
Andrew Welch
Dr Ivan Zammit-Maempel
et al. | Thyroid gland invasion in total laryngectomy and total laryngopharyngectomy: a systematic review and meta-analysis of the English literature | 2013 |
|
Professor Philip Sloan
Dr Max Robinson
| Validation of a novel diagnostic standard in HPV-positive oropharyngeal squamous cell carcinoma | 2013 |
|
Dr Max Robinson
| Detection of Oncogenic Human Papillomavirus in Nasopharyngeal Carcinoma | 2012 |
|
Dr Timothy Bates
Dr Tuomo Polvikoski
Professor Philip Sloan
Dr David Meikle
Dr Max Robinson
et al. | Ganglioneuroblastic transformation in olfactory neuroblastoma | 2012 |
|
Dr Max Robinson
Professor Philip Sloan
| HPV specific testing: a requirement for oropharyngeal squamous cell carcinoma patients | 2012 |
|
Dr Max Robinson
Professor Vinidh Paleri
| Salivary gland swellings | 2012 |
|
Dr Max Robinson
| The Pathology of Virus-Related Carcinomas of the Upper Aerodigestive Tract | 2012 |
|
Professor Philip Sloan
Dr Max Robinson
| Validation for a novel diagnostic standard in HPV-positive oropharyngeal squamous cell carcinoma. | 2012 |
|
Dr Max Robinson
Professor Philip Sloan
| Evaluation of human papilloma virus diagnostic testing in oropharyngeal squamous cell carcinoma: sensitivity, specificity and prognostic discrimination | 2011 |
|
Professor Philip Sloan
Dr Max Robinson
| Evaluation of human papillomavirus testing for squamous cell carcinoma of the tonsil in clinical practice | 2011 |
|
Dr Christine Challen
Professor Philip Sloan
Professor Mark Birch-Machin
Dr Max Robinson
| Mitochondrial DNA mutations in head and neck cancer are infrequent and lack prognostic utility | 2011 |
|
Dr Max Robinson
| Squamous cell carcinoma of the oral cavity rarely harbours oncogenic human papillomavirus | 2011 |
|
Robert Shaw
Dr Max Robinson
| The increasing clinical relevance of human papillomavirus type 16 (HPV-16) infection in oropharyngeal cancer | 2011 |
|
Dr Max Robinson
Professor Philip Sloan
| CD56 (NCAM) expression in ameloblastomas and other odontogenic lesions | 2010 |
|
Dr Max Robinson
Professor Philip Sloan
| Refining the diagnosis of oropharyngeal squamous cell carcinoma using human papillomavirus testing | 2010 |
|
Dr Max Robinson
| Upregulation of Eps8 in oral squamous cell carcinoma promotes cell migration and invasion through integrin-dependent Rac1 activation | 2009 |
|
Professor Vinidh Paleri
Dr Max Robinson
| Polymorphous low-grade adenocarcinoma of the head and neck | 2008 |
|
Dr Max Robinson
| Expression of Ki-67 and p53 in cutaneous free flaps used to reconstruct soft tissue defects following resection of oral squamous cell carcinoma | 2007 |
|
Dr Max Robinson
| Spindle assembly checkpoint and centrosome abnormalities in oral cancer | 2007 |
|
Dr Max Robinson
| An investigation into the practice of tongue piercing in the South West of England | 2006 |
|
Dr Max Robinson
| Lichenoid and granulomatous stomatitis: an entity or a non-specific inflammatory process? | 2006 |
|
Dr Max Robinson
| Induction of an epithelial to mesenchymal transition in human immortal and malignant keratinocytes by TGF-β1 involves MAPK, Smad and AP-1 signalling pathways | 2005 |
|
Dr Max Robinson
| Attenuated type II TGF-β receptor signalling in human malignant oral keratinocytes induces a less differentiated and more aggressive phenotype that is associated with metastatic dissemination | 2004 |
|
Dr Max Robinson
| Metastatic dissemination of human malignant oral keratinocyte cell lines following orthotopic transplantation reflects response to TGF-β1 | 2004 |
|
Dr Max Robinson
| A study of the clinical characteristics of benign trigeminal sensory neuropathy | 2003 |
|
Dr Max Robinson
| Functional significance of MMP-2 and MMP-9 expression by human malignant oral keratinocyte cell lines | 2003 |
|
Dr Max Robinson
| TGF-β1 acts as a tumor suppressor of human malignant keratinocytes independently of Smad 4 expression and ligand-induced G1 arrest | 2002 |
|
Dr Max Robinson
| Decreased expression of TGF-β cell surface receptors during progression of human oral squamous cell carcinoma | 2001 |
|
Dr Max Robinson
| Overexpression of JunB in undifferentiated malignant rat oral keratinocytes enhances the malignant phenotype in vitro without altering cellular differentiation | 2001 |
|
Dr Max Robinson
| Oral Psoriasis | 1996 |
|
